Diabetes, metformin and glucose lowering therapies after myocardial infarction: Insights from the SWEDEHEART registry

OBJECTIVE: To explore real-life use of glucose lowering drugs and prognosis after acute myocardial infarction (AMI) with a special focus on metformin. METHODS: Patients (n = 70270) admitted for AMI 2012–2017 were stratified by diabetes status and glucose lowering treatment and followed for mortality...

Descripción completa

Detalles Bibliográficos
Autores principales: Ritsinger, Viveca, Lagerqvist, Bo, Lundman, Pia, Hagström, Emil, Norhammar, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7919225/
https://www.ncbi.nlm.nih.gov/pubmed/33231125
http://dx.doi.org/10.1177/1479164120973676

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7919225/
https://www.ncbi.nlm.nih.gov/pubmed/33231125
http://dx.doi.org/10.1177/1479164120973676

Ejemplares similares